First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide,...
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
About this item
Full title
Author / Creator
Eichhorst, Barbara, Dr , Fink, Anna-Maria, MD , Bahlo, Jasmin, PhD , Busch, Raymonde, Dipl Math , Kovacs, Gabor, MD , Maurer, Christian, MD , Lange, Elisabeth, MD , Köppler, Hubert, Prof , Kiehl, Michael, Prof , Sökler, Martin, MD , Schlag, Rudolf, MD , Vehling-Kaiser, Ursula, MD , Köchling, Georg, MD , Plöger, Christoph, MD , Gregor, Michael, MD , Plesner, Torben, MD , Trneny, Marek, Prof , Fischer, Kirsten, MD , Döhner, Harmut, Prof , Kneba, Michael, Prof , Wendtner, Clemens-Martin, Prof , Klapper, Wolfram, Prof , Kreuzer, Karl-Anton, Prof , Stilgenbauer, Stephan, Prof , Böttcher, Sebastian, MD , Hallek, Michael, Prof , German CLL Study Group (GCLLSG) and international group of investigators
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundChemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab is the standard therapy for physically fit patients with advanced chronic lymphocytic leukaemia. This international phase 3 study compared the efficacy and tolerance of the standard therapy with a potentially less toxic combination consisting of bendamustine and r...
Alternative Titles
Full title
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Authors, Artists and Contributors
Author / Creator
Fink, Anna-Maria, MD
Bahlo, Jasmin, PhD
Busch, Raymonde, Dipl Math
Kovacs, Gabor, MD
Maurer, Christian, MD
Lange, Elisabeth, MD
Köppler, Hubert, Prof
Kiehl, Michael, Prof
Sökler, Martin, MD
Schlag, Rudolf, MD
Vehling-Kaiser, Ursula, MD
Köchling, Georg, MD
Plöger, Christoph, MD
Gregor, Michael, MD
Plesner, Torben, MD
Trneny, Marek, Prof
Fischer, Kirsten, MD
Döhner, Harmut, Prof
Kneba, Michael, Prof
Wendtner, Clemens-Martin, Prof
Klapper, Wolfram, Prof
Kreuzer, Karl-Anton, Prof
Stilgenbauer, Stephan, Prof
Böttcher, Sebastian, MD
Hallek, Michael, Prof
German CLL Study Group (GCLLSG)
international group of investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1808669623
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808669623
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(16)30051-1
